ArticleCancer medicine2024

Added value of whole-exome and RNA sequencing in advanced and refractory cancer patients with no molecular-based treatment recommendation based on a 90-gene panel.

Armelle Dufresne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.